Couch grass root, bearberry leaves, White birch leaves, shepherd's purse herb, horsetail herb, hauhechel herb, hauhechel root, parsley fruit, parsley root, Real gold Hanging rod herb, Cytisus scoparius e floribus cum cuprum colloidal spag. (Pot.-Information) - hasil pencarian

sanofi-aventis groupe - irbesartan, hydrochlorothiazid - forhøjet blodtryk - agenter, der virker på renin-angiotensinsystemet - behandling af essentiel hypertension. denne fastdosekombination er indiceret hos voksne patienter, hvis blodtryk ikke kontrolleres tilstrækkeligt på alene irbesartan eller hydrochlorothiazid.

Denmark - Dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

irbesartan/hydrochlorthiazid "stada" 300+12,5 mg filmovertrukne tabletter

stada arzneimittel ag - hydrochlorthiazid, irbesartan - filmovertrukne tabletter - 300+12,5 mg

Denmark - Dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

irbesartan/hydrochlorthiazid "stada" 300+25 mg filmovertrukne tabletter

stada arzneimittel ag - hydrochlorthiazid, irbesartan - filmovertrukne tabletter - 300+25 mg

Uni Eropa - Dansk - EMA (European Medicines Agency)

sitagliptin / metformin hydrochloride mylan

mylan ireland limited - sitagliptin hydrochloride monohydrate, metformin hydrochloride - diabetes mellitus, type 2 - narkotika anvendt i diabetes - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride mylan is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride mylan is indicated in combination with a sulphonylurea (i. - , trepersoners-kombinationsbehandling) som supplement til diæt og motion hos patienter, der ikke er tilstrækkeligt kontrolleret på deres maksimal tolereret dosis af metformin og et sulphonylurea. sitagliptin/metformin hydrochloride mylan is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparg) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparg agonist. sitagliptin/metformin hydrochloride mylan is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.